Sign Up to like & get
recommendations!
0
Published in 2017 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1535-7163.mct-17-0013
Abstract: Taxane-based therapy provides a survival benefit in patients with metastatic prostate cancer, yet the median survival is less than 20 months in this setting due in part to taxane-associated resistance. Innovative strategies are required to…
read more here.
Keywords:
taxane;
taxane resistant;
prostate cancer;
cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Cancer Research"
DOI: 10.1158/1538-7445.am2020-3000
Abstract: Ovarian cancer has few targeted therapies and high rates of metastasis. Taxane microtubule stabilizers, including paclitaxel, are a mainstay in the treatment of adult solid tumors as single agents and in combination with other cytotoxic…
read more here.
Keywords:
microtubule stabilizers;
efficacy;
ovarian cancer;
cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Oncotarget"
DOI: 10.18632/oncotarget.23235
Abstract: Docetaxel (DTX) is widely used for metastatic castrated resistant prostate cancer, but its efficacy is often compromised by drug resistance associated with low intracellular concentrations. Piperine (PIP) could enhance the bioavailability of other drugs via…
read more here.
Keywords:
taxane resistant;
prostate cancer;
dtx;
resistant prostate ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Genes"
DOI: 10.3390/genes14020296
Abstract: A limited number of studies are devoted to regulating TRIP6 expression in cancer. Hence, we aimed to unveil the regulation of TRIP6 expression in MCF-7 breast cancer cells (with high TRIP6 expression) and taxane-resistant MCF-7…
read more here.
Keywords:
breast cancer;
mcf;
resistant mcf;
taxane resistant ... See more keywords